Elizabeth Alcorn currently leads Big Health’s rapidly growing Client Success organization. As a pioneer in the digital therapeutics space, Big Health is a true category creator whose clinical and evidence-based therapeutics have been adopted by numerous Fortune 100 companies. Sleepio, Big Health’s digital therapeutic for insomnia, was recently the first ever digital therapeutic to receive guidance from the National Institute for Health and Care Excellence (NICE) as a more clinically and cost-effective treatment than other standards of care. Prior to Big Health, Alcorn was with Healthgrades (now WebMD), where her humble, collaborative, and customer-centric approach continually exceeded expectations and delivered triple-digit growth. Alcorn received her BS in Molecular, Cellular, and Developmental Biology from the University of Colorado, Boulder. Additionally, she holds an MBS in Bioscience Business from Keck Graduate Institute.
You're Invited to Join KGI for our In-Person Visit Day! October 19 | 9 a.m. - 2:30 p.m. PST. REGISTER TODAY.